ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,825Medicare Part D Prescriptions Filled, Including Refills

Rank: 304 out of 917

$266K Total Retail Price of All Prescriptions

Rank: 399 out of 917

384 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 384 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 384 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

0% of this provider’s 5,473 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
ATENOLOL 352 331 1 12
SIMVASTATIN 327 309 2 2
LISINOPRIL 271 252 3 1
OMEPRAZOLE 215 208 4 4
HYDROCODONE-ACETAMINOPHEN 174 163 S3 5 6
LOSARTAN POTASSIUM 157 143 6 13
PAROXETINE HCL 156 150 7 57
AMLODIPINE BESYLATE 155 147 8 5
FLUTICASONE PROPIONATE 140 135 9 26
METFORMIN HCL 136 124 10 8
PRAVASTATIN SODIUM 131 123 11 20
FUROSEMIDE 130 127 12 7
K-TAB 128 122 13 111
WARFARIN SODIUM 119 113 14 10
LEVOTHROID 115 110 15 94
GABAPENTIN 87 78 16 17
MELOXICAM 83 80 17 53
TRIAMTERENE-HYDROCHLOROTHIAZID 82 73 18 147
TERAZOSIN HCL 76 72 19 108
PROAIR HFA 75 73 20 35
NOVOLIN N 69 66 21 125
TRAZODONE HCL 69 69 21 22
LEVOTHYROXINE SODIUM 66 61 23 3
FAMOTIDINE 65 64 24 91
SERTRALINE HCL 63 55 25 24
ADACEL 63 61 25 131
PANTOPRAZOLE SODIUM 61 52 27 44
TAMSULOSIN HCL 58 58 28 25
QVAR 57 55 29 167
ALENDRONATE SODIUM 57 57 29 23
METOPROLOL TARTRATE 55 54 31 11
INSULIN SYRINGE 54 50 32 83
ZOLPIDEM TARTRATE 52 43 33 21
ALLOPURINOL 52 46 33 31
DILT-XR 51 49 35 317
FLUOXETINE HCL 50 49 36 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.